Table of Content - Middle East And Asia Pacific Biotechnology Market

Biotechnology is a broad field that deals with the use of living organisms to create products that are beneficial to long-term development. It uses cellular and molecular processes to create products and technologies that may improve human life on Earth. It has a number of applications that are concerned with human welfare such as it has helped in reducing infectious disease rates; saving the lives of millions of children; changing the odds of serious, life-threatening conditions that affect millions around the world; tailoring treatments to individuals to minimize health risks and side effects; developing more precise disease detection tools; and combating serious diseases.

Moreover, to create microscopic manufacturing plants, biotech employs biological processes such as fermentation and biocatalysts such as enzymes, yeast, and other microbes.

Market Dynamics

Market players are focused on strategies such as partnerships, which is expected to contribute to the growth of the Middle East and Asia Pacific biotechnology market over the forecast period. For instance, in July 2021, Biocon Limited, an India-based biotechnology company announced a partnership with Tabuk Pharmaceutical Manufacturing Company, a leading pharmaceutical company in the Middle East and North Africa (MENA) to commercialize select specialty products that are some high quality, vertically-integrated generic formulations in the Middle East.

In addition, market players are engaged in enhancing their existing technology for production of biotechnology products, which is expected to positively impact growth of the Middle East and Asia Pacific biotechnology market over the forecast period. For instance, in February 2017, Jala Group, a China-based domestic cosmetic company successfully used its 3D bioprinting technology to print synthetic Asian skin for the first time, after conducting 98 experiments for the same.

Governments of countries in the Middle East and Asia Pacific are engaged in several activities such as supporting regulatory approvals of biotechnology products, making investments in research and development of novel biotechnology products, and others. These are expected to fuel the Middle East and Asia Pacific biotechnology market growth over the forecast period. For instance, in August 2021, the Central Council for Research in Siddha (CCRS), Government of India introduced its new startup initiative called Academia-industry Research Incubation for Value-chain Up-gradation (ARIVU), in order to motivate academia and industry to carry out research in industries such as biotechnology and nanotechnology.

Key features of the study:

This report provides an in-depth analysis of Middle East and Asia Pacific biotechnology market, market size (US$ Billion), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the Middle East and Asia Pacific biotechnology market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, Pfizer Inc., Abbvie Inc., Biocon, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Astrazeneca Plc., Illumina, Inc., Sanofi S.A., Qiagen, Twist Bioscience, Thermo Fisher Scientific Inc., Biointron, Merck & Co., Inc., Sino Biological Inc., GeneWiz (Azenta Life Sciences), Danaher Corporation, and Synbio Technologies.
Insights from this report would allow marketers and the management authorities of the companies to make an informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The Middle East and Asia Pacific biotechnology market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the Middle East and Asia Pacific biotechnology market

Detailed Segmentation:

Middle East and Asia Pacific Biotechnology Market, By Technology:
- Nanobiotechnology
- Tissue Engineering and Regeneration
- Fermentation
- Cell Based Assay
- CRISPR
- Others
Middle East and Asia Pacific Biotechnology Market, By Application:
- Molecular Biology
- Gene Synthesis
- Gene Editing
- Mammalian Protein Expression
- Recombinant Antibody Expression
- Peptide Synthesis
- Protein Expression
- Monoclonal and Polyclonal Antibody Generation
- Others
Middle East and Asia Pacific Biotechnology Market, By End User:
- Biotechnology & Pharmaceutical Companies
- Research Institutes & Laboratories
- Academic Institutions
- Others
Middle East and Asia Pacific Biotechnology Market, By Region:
- Asia Pacific
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
Company Profiles
- Abbott Laboratories*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Pfizer Inc.
- Abbvie Inc.
- Biocon
- F. Hoffmann-La Roche Ltd.
- PerkinElmer, Inc.
- AstraZeneca Plc.
- Illumina, Inc.
- Sanofi S.A.
- Qiagen
- Twist Bioscience
- Thermo Fisher Scientific Inc.
- Biointron
- Merck & Co., Inc.
- Sino Biological Inc.
- GeneWiz (Azenta Life Sciences)
- Danaher Corporation
- Synbio Technologies

“*” marked represents similar segmentation in other categories in the respective section.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Technology
  - Market Snippet, By Application
  - Market Snippet, By End User
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Porter’s Analysis
- Industry Trends
- Key Highlights
- Epidemiology
- Reimbursement Scenario
- Regulatory Scenario
- Product Launch and Approvals
- Acquisition and Collaboration Scenario
Middle East and Asia Pacific Biotechnology Market - Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Biotechnology Market
- Impact of COVID-19 on the Overall Healthcare Sector
Middle East and Asia Pacific Biotechnology Market, By Technology, 2017-2030 (US$ Billion)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018-2030
  - Segment Trends
- Nanobiotechnology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Tissue Engineering and Regeneration
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Fermentation
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Cell Based Assay
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- CRISPR
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Middle East and Asia Pacific Biotechnology Market, By Application, 2017-2030 (US$ Billion)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018-2030
  - Segment Trends
- Molecular Biology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Gene Synthesis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Gene Editing
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Mammalian Protein Expression
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Recombinant Antibody Expression
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Peptide Synthesis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Protein Expression
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Monoclonal and Polyclonal Antibody Generation
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Middle East and Asia Pacific Biotechnology Market, By End User, 2017-2030 (US$ Billion)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018-2030
  - Segment Trends
- Biotechnology & Pharmaceutical Companies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Research Institutes & Laboratories
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Academic Institutions
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Middle East and Asia Pacific Biotechnology Market, By Region, 2017-2030 (US$ Billion)
- Introduction
  - Market Share Analysis, By Region, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018-2030
  - Regional Trends
- Asia Pacific
  - Market Size and Forecast, By Technology, 2017-2030 (US$ Billion)
  - Market Size and Forecast, By Application, 2017-2030 (US$ Billion)
  - Market Size and Forecast, By End User, 2017-2030 (US$ Billion)
  - Market Size and Forecast, By Country, 2017-2030 (US$ Billion)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Market Size and Forecast, By Technology, 2017-2030 (US$ Billion)
  - Market Size and Forecast, By Application, 2017-2030 (US$ Billion)
  - Market Size and Forecast, By End User, 2017-2030 (US$ Billion)
  - Market Size and Forecast, By Country, 2017-2030 (US$ Billion)
    - GCC
    - Israel
    - Rest of Middle East
Competitive Landscape
- Company Profiles
  - Abbott Laboratories*
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - Pfizer Inc.
  - Abbvie Inc.
  - Biocon
  - F. Hoffmann-La Roche Ltd.
  - PerkinElmer, Inc.
  - AstraZeneca Plc.
  - Illumina, Inc.
  - Sanofi S.A.
  - Qiagen
  - Twist Bioscience
  - Thermo Fisher Scientific Inc.
  - Biointron
  - Merck & Co., Inc.
  - Sino Biological Inc.
  - GeneWiz (Azenta Life Sciences)
  - Danaher Corporation
  - Synbio Technologies

*Key pointers provided are also applicable to other companies covered in the scope of the report.

Analyst Views

Section
- Research Methodology
- About us
- Contact

*Browse 106 market data tables and 132 figures on “Biotechnology Market” – Middle East and Asia Pacific Forecast to 2030.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount